CN104644523A - 一种医用生物除皱抑斑敷料及其制备方法 - Google Patents
一种医用生物除皱抑斑敷料及其制备方法 Download PDFInfo
- Publication number
- CN104644523A CN104644523A CN201510040373.6A CN201510040373A CN104644523A CN 104644523 A CN104644523 A CN 104644523A CN 201510040373 A CN201510040373 A CN 201510040373A CN 104644523 A CN104644523 A CN 104644523A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- speckle
- dressing
- oil
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 230000002401 inhibitory effect Effects 0.000 title abstract 3
- 230000037303 wrinkles Effects 0.000 claims abstract description 99
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 74
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 68
- 102000008186 Collagen Human genes 0.000 claims abstract description 51
- 108010035532 Collagen Proteins 0.000 claims abstract description 51
- 239000003102 growth factor Substances 0.000 claims abstract description 51
- 239000000843 powder Substances 0.000 claims abstract description 47
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 45
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 44
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 44
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 37
- 239000010495 camellia oil Substances 0.000 claims abstract description 37
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 37
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 37
- 229940046009 vitamin E Drugs 0.000 claims abstract description 37
- 239000011709 vitamin E Substances 0.000 claims abstract description 37
- 235000008390 olive oil Nutrition 0.000 claims abstract description 35
- 239000004006 olive oil Substances 0.000 claims abstract description 35
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 34
- 235000001014 amino acid Nutrition 0.000 claims abstract description 34
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 34
- 239000011718 vitamin C Substances 0.000 claims abstract description 34
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 33
- 241000208152 Geranium Species 0.000 claims abstract description 33
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 33
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 33
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 33
- 239000011719 vitamin A Substances 0.000 claims abstract description 33
- 229940045997 vitamin a Drugs 0.000 claims abstract description 33
- 150000001413 amino acids Chemical class 0.000 claims abstract description 32
- 244000293323 Cosmos caudatus Species 0.000 claims description 45
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 45
- 235000019489 Almond oil Nutrition 0.000 claims description 34
- 239000008168 almond oil Substances 0.000 claims description 34
- 239000002994 raw material Substances 0.000 claims description 25
- -1 Oleum menthae Substances 0.000 claims description 12
- 108010025020 Nerve Growth Factor Proteins 0.000 claims description 7
- 102000015336 Nerve Growth Factor Human genes 0.000 claims description 7
- 108010009583 Transforming Growth Factors Proteins 0.000 claims description 7
- 102000009618 Transforming Growth Factors Human genes 0.000 claims description 7
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 7
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 7
- 229940053128 nerve growth factor Drugs 0.000 claims description 7
- 210000000130 stem cell Anatomy 0.000 claims description 6
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims description 5
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 4
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 4
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 4
- 229940116977 epidermal growth factor Drugs 0.000 claims description 4
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 4
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 4
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims description 3
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims 1
- 206010040954 Skin wrinkling Diseases 0.000 abstract description 93
- 230000000694 effects Effects 0.000 abstract description 46
- 229920001436 collagen Polymers 0.000 abstract description 10
- 230000002087 whitening effect Effects 0.000 abstract description 10
- 206010040925 Skin striae Diseases 0.000 abstract description 9
- 230000008929 regeneration Effects 0.000 abstract description 7
- 238000011069 regeneration method Methods 0.000 abstract description 7
- 208000027418 Wounds and injury Diseases 0.000 abstract description 6
- 206010052428 Wound Diseases 0.000 abstract description 5
- 239000003921 oil Substances 0.000 abstract description 5
- 235000019198 oils Nutrition 0.000 abstract description 5
- 231100000241 scar Toxicity 0.000 abstract description 4
- 210000000056 organ Anatomy 0.000 abstract description 2
- 230000036560 skin regeneration Effects 0.000 abstract description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 239000010647 garlic oil Substances 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 abstract 1
- 239000000341 volatile oil Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 82
- 239000000203 mixture Substances 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 18
- 230000006870 function Effects 0.000 description 17
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 14
- 210000000589 cicatrix Anatomy 0.000 description 11
- 230000003020 moisturizing effect Effects 0.000 description 10
- 210000004927 skin cell Anatomy 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000001815 facial effect Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 230000012010 growth Effects 0.000 description 7
- 230000009759 skin aging Effects 0.000 description 7
- 206010000496 acne Diseases 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 208000002874 Acne Vulgaris Diseases 0.000 description 5
- 241000863032 Trieres Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 206010008570 Chloasma Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010042496 Sunburn Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 238000010612 desalination reaction Methods 0.000 description 4
- 210000001061 forehead Anatomy 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000019522 cellular metabolic process Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- 108060006004 Ascorbate peroxidase Proteins 0.000 description 2
- DZNVIZQPWLDQHI-UHFFFAOYSA-N Citronellyl formate Chemical compound O=COCCC(C)CCC=C(C)C DZNVIZQPWLDQHI-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- 241000700647 Variola virus Species 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 244000147058 Derris elliptica Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000003759 Erodium cicutarium Species 0.000 description 1
- 235000009967 Erodium cicutarium Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020651 Hyperkinesia Diseases 0.000 description 1
- 208000000269 Hyperkinesis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical compound C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000167686 Reichardia Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 229940116978 human epidermal growth factor Drugs 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940094944 saccharide isomerate Drugs 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510040373.6A CN104644523B (zh) | 2015-01-27 | 2015-01-27 | 一种医用生物除皱抑斑敷料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510040373.6A CN104644523B (zh) | 2015-01-27 | 2015-01-27 | 一种医用生物除皱抑斑敷料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104644523A true CN104644523A (zh) | 2015-05-27 |
CN104644523B CN104644523B (zh) | 2018-07-03 |
Family
ID=53236501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510040373.6A Active CN104644523B (zh) | 2015-01-27 | 2015-01-27 | 一种医用生物除皱抑斑敷料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104644523B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940046A (zh) * | 2015-07-27 | 2015-09-30 | 广西信业生物技术有限公司 | 一种医用生物紧肤敷料及其制备方法 |
CN105039030A (zh) * | 2015-08-06 | 2015-11-11 | 吴敏 | 一种预防妊娠纹的香皂及其制备方法 |
CN105055187A (zh) * | 2015-09-14 | 2015-11-18 | 广州赛莱拉干细胞科技股份有限公司 | 一种面部年轻化美容制剂及其制备方法 |
CN105106093A (zh) * | 2015-09-14 | 2015-12-02 | 广州赛莱拉干细胞科技股份有限公司 | 一种面部年轻化美容制剂及其制备方法 |
CN105534746A (zh) * | 2015-12-25 | 2016-05-04 | 青岛海特新蓝生物科技有限公司 | 一种按摩用修复妊娠纹精油 |
CN107811894A (zh) * | 2017-12-15 | 2018-03-20 | 广东澳元健集团有限公司 | 一种具有橄榄油的护肤膏及其制备方法 |
CN108143649A (zh) * | 2018-03-15 | 2018-06-12 | 深圳市婴缘健康有限公司 | 一种孕妇淡纹油 |
CN109394989A (zh) * | 2018-12-25 | 2019-03-01 | 佛山科学技术学院 | 一种消除妊娠纹的中药修复液及其制备方法 |
CN109771329A (zh) * | 2019-03-08 | 2019-05-21 | 储殷 | 改善皮肤保水功能、保龄祛皱的组合物及其制备方法 |
CN109966178A (zh) * | 2017-12-27 | 2019-07-05 | 太阳星光齿磨公司 | 皮肤外用组合物及赋予或增强抗皱纹效果的方法 |
CN112891608A (zh) * | 2021-01-29 | 2021-06-04 | 西安建筑科技大学 | 一种细菌纤维素基丝胶薄荷油纳米粒子的伤口敷料及其制备方法 |
CN114159545A (zh) * | 2021-12-29 | 2022-03-11 | 北京远胜达生物科技发展有限公司 | 一种含有酵素的美白抗皱组合物及其在药品中的应用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230363988A1 (en) * | 2020-09-24 | 2023-11-16 | Biogen Stemceuticals, Inc. | Compositions for improved skin appearance and methods of use thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101040824A (zh) * | 2007-04-20 | 2007-09-26 | 厦门大学 | 对二甲氨基苯甲醛缩氨基硫脲在美白化妆品中的应用 |
CN103169641A (zh) * | 2013-03-14 | 2013-06-26 | 金红叶纸业集团有限公司 | 祛痘淡印组合物及应用其的纸巾 |
CN103340801A (zh) * | 2013-07-18 | 2013-10-09 | 广州市一卡拉康美生物科技有限公司 | 一种针对皮肤细胞生长的关键养护方法 |
CN103536510A (zh) * | 2013-10-17 | 2014-01-29 | 苏州威尔德工贸有限公司 | 一种祛痘膏及其制备方法 |
CN104248523A (zh) * | 2013-06-26 | 2014-12-31 | 青岛道合生物科技有限公司 | 一种植物美白祛斑乳液 |
CN104288828A (zh) * | 2014-10-29 | 2015-01-21 | 广西信业生物技术有限公司 | 一种医用生物抑瘢除皱敷料及其制备方法 |
-
2015
- 2015-01-27 CN CN201510040373.6A patent/CN104644523B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101040824A (zh) * | 2007-04-20 | 2007-09-26 | 厦门大学 | 对二甲氨基苯甲醛缩氨基硫脲在美白化妆品中的应用 |
CN103169641A (zh) * | 2013-03-14 | 2013-06-26 | 金红叶纸业集团有限公司 | 祛痘淡印组合物及应用其的纸巾 |
CN104248523A (zh) * | 2013-06-26 | 2014-12-31 | 青岛道合生物科技有限公司 | 一种植物美白祛斑乳液 |
CN103340801A (zh) * | 2013-07-18 | 2013-10-09 | 广州市一卡拉康美生物科技有限公司 | 一种针对皮肤细胞生长的关键养护方法 |
CN103536510A (zh) * | 2013-10-17 | 2014-01-29 | 苏州威尔德工贸有限公司 | 一种祛痘膏及其制备方法 |
CN104288828A (zh) * | 2014-10-29 | 2015-01-21 | 广西信业生物技术有限公司 | 一种医用生物抑瘢除皱敷料及其制备方法 |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940046B (zh) * | 2015-07-27 | 2018-06-19 | 广西信业生物技术有限公司 | 一种医用生物紧肤敷料及其制备方法 |
CN104940046A (zh) * | 2015-07-27 | 2015-09-30 | 广西信业生物技术有限公司 | 一种医用生物紧肤敷料及其制备方法 |
CN105039030A (zh) * | 2015-08-06 | 2015-11-11 | 吴敏 | 一种预防妊娠纹的香皂及其制备方法 |
CN105055187A (zh) * | 2015-09-14 | 2015-11-18 | 广州赛莱拉干细胞科技股份有限公司 | 一种面部年轻化美容制剂及其制备方法 |
CN105106093A (zh) * | 2015-09-14 | 2015-12-02 | 广州赛莱拉干细胞科技股份有限公司 | 一种面部年轻化美容制剂及其制备方法 |
CN105055187B (zh) * | 2015-09-14 | 2018-02-09 | 广州赛莱拉干细胞科技股份有限公司 | 一种面部年轻化美容制剂及其制备方法 |
CN105534746A (zh) * | 2015-12-25 | 2016-05-04 | 青岛海特新蓝生物科技有限公司 | 一种按摩用修复妊娠纹精油 |
CN107811894A (zh) * | 2017-12-15 | 2018-03-20 | 广东澳元健集团有限公司 | 一种具有橄榄油的护肤膏及其制备方法 |
CN109966178A (zh) * | 2017-12-27 | 2019-07-05 | 太阳星光齿磨公司 | 皮肤外用组合物及赋予或增强抗皱纹效果的方法 |
JP2019119737A (ja) * | 2017-12-27 | 2019-07-22 | サンスター株式会社 | 皮膚外用組成物 |
CN108143649A (zh) * | 2018-03-15 | 2018-06-12 | 深圳市婴缘健康有限公司 | 一种孕妇淡纹油 |
CN109394989A (zh) * | 2018-12-25 | 2019-03-01 | 佛山科学技术学院 | 一种消除妊娠纹的中药修复液及其制备方法 |
CN109771329A (zh) * | 2019-03-08 | 2019-05-21 | 储殷 | 改善皮肤保水功能、保龄祛皱的组合物及其制备方法 |
CN112891608A (zh) * | 2021-01-29 | 2021-06-04 | 西安建筑科技大学 | 一种细菌纤维素基丝胶薄荷油纳米粒子的伤口敷料及其制备方法 |
CN112891608B (zh) * | 2021-01-29 | 2022-05-24 | 西安建筑科技大学 | 一种细菌纤维素基丝胶薄荷油纳米粒子的伤口敷料及其制备方法 |
CN114159545A (zh) * | 2021-12-29 | 2022-03-11 | 北京远胜达生物科技发展有限公司 | 一种含有酵素的美白抗皱组合物及其在药品中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104644523B (zh) | 2018-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104644523B (zh) | 一种医用生物除皱抑斑敷料及其制备方法 | |
CN104288828B (zh) | 一种医用生物抑瘢除皱敷料及其制备方法 | |
CN104921983A (zh) | 一种孕妇妊娠纹医用生物修复敷料及其制备方法 | |
CN106511220A (zh) | 一种铁皮石斛滋润修复睡眠面膜及其制备方法 | |
CN104667335A (zh) | 皮肤屏障功能或痔的重组人源胶原蛋白产品及制备方法 | |
CN108553389A (zh) | 一种植物保湿晒后修复霜及其制备方法 | |
CN105193673B (zh) | 一种清痘修复液及其制备方法 | |
CN108653013A (zh) | 一种植物保湿水润晒后修复霜及其制备方法 | |
CN104983646A (zh) | 夜用养护面膜液及其制备方法 | |
CN108653006A (zh) | 一种植物保湿全效眼霜及其制备方法 | |
CN107303253A (zh) | 一种用于受损肌肤的修复剂及其制备方法 | |
CN109431912A (zh) | 皮肤油脂平衡组合物及其应用 | |
CN112842943A (zh) | 一种止痒保湿修护肌肤的乳霜及其制备方法 | |
CN104825347B (zh) | 一种医用生物美白袪斑敷料及其制备方法 | |
CN1813669A (zh) | 祛皱眼贴及制备产品的方法 | |
CN109172491A (zh) | 一种具有抗衰老和活血化瘀功能的霜剂及其制备方法 | |
CN106333880B (zh) | 一种稀薄乳液基质的爽肤水及其制备方法 | |
CN109381390A (zh) | 一种玻尿酸亮肤修护面膜及其制备方法 | |
CN103316157A (zh) | 一种治疗妊娠纹的复方精油 | |
RU2121341C1 (ru) | Лечебно-косметический крем | |
CN105213279A (zh) | 一种消除萎缩纹的身体乳及其制备方法 | |
CN104548190B (zh) | 一种医用生物丰乳敷料及其制备方法 | |
CN103271861A (zh) | 一种防晒保湿护理面霜 | |
CN101185622B (zh) | 控油防黑白嫩霜 | |
CN108542847A (zh) | 一种祛除痘、疖及去痘印的组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 537300, Guigang County, the Guangxi Zhuang Autonomous Region, Linjiang Industrial Park, third feeder roads and access to the South Road junction, Guangxi grand Biological Technology Co., Ltd. Applicant after: GUANGXI DAQING BIOTECHNOLOGY Co.,Ltd. Address before: 537300, Guigang County, the Guangxi Zhuang Autonomous Region, Linjiang Industrial Park, third feeder roads and access to the South Road junction, Guangxi grand Biological Technology Co., Ltd. Applicant before: GUANGXI DAQING BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD. |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 537300 Pingnan County Industrial Park, Guigang City, the Guangxi Zhuang Autonomous Region Patentee after: GUANGXI DAQING BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD. Address before: 537300 the Guangxi Zhuang Autonomous Region, Guigang City, Pingnan County Linjiang Industrial Park third branch road and the junction of the South Road, Guangxi Daqing Biotechnology Co., Ltd. Patentee before: GUANGXI DAQING BIOTECHNOLOGY Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150527 Assignee: GUANGXI XINYE BIOLOGICAL TECHNOLOGY Co.,Ltd. Assignor: GUANGXI DAQING BIOLOGICAL SCIENCE & TECHNOLOGY CO.,LTD. Contract record no.: X2023980043753 Denomination of invention: A medical biological wrinkle removal and spot suppression dressing and its preparation method Granted publication date: 20180703 License type: Common License Record date: 20231019 |